New hope for stoma patients: drug cuts dangerous fluid loss
NCT ID NCT02713776
First seen Dec 26, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tested a drug called pasireotide in 57 adults who had bowel surgery and a stoma (enterostomy) that produced too much fluid, even after standard treatments. The goal was to see if pasireotide could reduce the amount of fluid lost through the stoma within 72 hours, helping patients avoid dehydration and kidney problems. Participants received either pasireotide or a placebo injection, and doctors measured the change in stoma output.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROSTOMY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bordeaux Chu - Hopital Haut-Leveque
Pessac, 33600, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Centre Leon Berard
Lyon, 69008, France
-
Chu Albert Michallon
La Tronche, 38700, France
-
Chu Amiens-Picardie
Amiens, 80054, France
-
Chu Caremeau
Nîmes, 30029, France
-
Chu Estaing
Clermont-Ferrand, 63003, France
-
Chu Marseille - Hopital Nord
Marseille, 13 915, France
-
Chu Rouen Ch. Nicolle
Rouen, 76031, France
-
Hopital Beaujon
Clichy, 92110, France
-
Hopital Saint Antoine
Paris, 75012, France
-
Hôpital Claude HURIEZ - CHRU Lille
Lille, 59 067, France
-
Institut Regional Du Cancer Val D'Aurelle
Montpellier, 34298, France
-
Toulouse - Chu Purpan
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.